Neuro-Oncology Reviews
Volume
27 Number 17
20 June 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 17, 20 June
Hersh
AM, Jillala R, Kramer P, Keating RF, Syed HR, Oluigbo CO, Groves
ML, Manbachi A, Theodore N, Woodworth GF, Cantor E, Senatus PB,
Hersh DS.
Focused
ultrasound in pediatric neurosurgery: a scoping review of
opportunities and challenges.
Childs
Nerv Syst.
2025 Jun 11;41(1):210. doi:
10.1007/s00381-025-06863-9. PMID:
40500553. Review˰ ˍ
Van den Ende B, Riva M, De Smet F, Jacobs S, Hulleman E, Coosemans
A.
Exploring the tumor
microenvironment in diffuse intrinsic pontine glioma:
immunological insights and therapeutic challenges.
J
Immunother Cancer. 2025 Jun 12;13(6):e012009. doi:
10.1136/jitc-2025-012009. PMID:
40514066. Review. ˍ
Salahlou R, Farajnia S, Alizadeh E, Dastmalchi S.
Recent
developments in peptide vaccines against Glioblastoma, a review
and update.
Mol
Brain. 2025 Jun 13;18(1):50. doi:
10.1186/s13041-025-01221-x. PMID:
40514725. Review. ˍ
Hammed A, Al-Qiami A, Hasan A, Richter G, Zakria Alnajjar A,
Rosenbauer J, Kostev K, Ismail O, Braun V, Tanislav C.
Efficacy
and safety of combining re-irradiation with bevacizumab compared
to bevacizumab alone in the management of recurrent high-grade
gliomas: a meta-analysis and systematic review.
Ther
Adv Neurol Disord. 2025 Jun 14;18:17562864251343574.
doi:
10.1177/17562864251343574. PMID:
40529988. Review; Meta-analysis. ˍ
Fang C, Zhang G, Ye S, Tian S, Li H, Zuo F, Wan J, Cai H.
Regulatory mechanisms of
O6-methylguanine methyltransferase expression in glioma cells.
Sci
Prog. 2025 Jun 16;108(2):368504251345014. doi:
10.1177/00368504251345014. PMID:
40519114. Review. ˍ
Möller C, Schoof M, Ligon KL, Schüller U.
Integration
of omics data in the diagnosis and therapy of glioblastoma.
Brain
Pathol. 2025 Jun 17:e70027. doi:
10.1111/bpa.70027. PMID:
40527506. Review. ˍ
Pepper NB, Troschel FM, Stummer W, Eich HT.
5-Aminolevulinic
acid as an emerging radiosensitizer for radiodynamic therapy in
solid tumors: a systematic review of available data and
clinical potential.
Strahlenther
Onkol. 2025 Jun 17. doi:
10.1007/s00066-025-02420-0. PMID:
40526132. Review. ˍ
Wang S, Wu J, Zhang W, Nie J.
Effects
and safety of TMZ plus RT combined with other drugs in the
treatment of glioblastoma: a network meta-analysis.
Future
Oncol. 2025 Jun 18;21(17):2237-2249. doi:
10.1080/14796694.2025.2516408. PMID:
40528440.
Meta-analysis˰ ˍ
Zhu J, Li X, Lin Z, Qu L, Guan H. 2009-2023
Bibliometric
analysis of the clinical value of graphene quantum dots in
glioblastoma treatment.
Discov
Nano. 2025 Jun 18;20(1):96. doi:
10.1186/s11671-025-04277-9. PMID:
40531247. Bibliometric analysis. ˍ
Belokon SV, Kukarskaya VA, Klabukov ID, Shestakova VA, Ivanov SA,
Shegay PV, Kaprin AD, Baranovskii DS.
A
Critical Review of CAR-T Therapies for Glioblastoma: What's Wrong
with the Current Attempts?
Hematol
Oncol Stem Cell Ther. 2025 Jun 20. doi:
10.4103/hemoncstem.HEMONCSTEM-D-24-00040. PMID:
40539476. Review. ˍ